ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Achillion Pharmaceuticals Inc

Achillion Pharmaceuticals Inc (ACHN)

6,76
0,00
(0,00%)
Geschlossen 28 November 10:00PM
6,76
0,00
( 0,00% )
Vor Marktöffnung: 1:00AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
6,76
Gebot
6,93
Fragen
6,75
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Handelsende
6,76
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

ACHN Neueste Nachrichten

Achillion Shareholders Approve Agreement to be Acquired by Alexion

BLUE BELL, Pa., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and...

Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...

– 2.4 g/dL mean increase in hemoglobin at 24 weeks –– Reduction in blood transfusions from 34 to 1; and improvements in markers of hemolysis –- Completed End of Phase 2 Meeting; Phase 3 Trial...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm PR Newswire NEW YORK, Nov. 22, 2019 NEW...

European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...

BLUE BELL, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and...

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and...

Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update

– Reached an agreement to be acquired by Alexion; transaction expected to close in first half of 2020 – – Danicopan (ACH-4471) received Breakthrough Therapy designation for treatment of PNH; Phase...

Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting

BLUE BELL, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc. PR Newswire NEW YORK, Oct. 18, 2019 NEW YORK, Oct. 18, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible...

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Alexion Pharmaceuticals, Inc. PR Newswire MILWAUKEE...

Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...

Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fair Deal? PR Newswire SAN DIEGO, Oct. 16, 2019 SAN DIEGO, Oct. 16, 2019...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PGHLPrimega Group Holdings Ltd
US$ 2,97
(80,00%)
9,27M
BMRABiomerica Inc
US$ 0,472
(46,54%)
3,68M
LGHLLion Group Holding Ltd
US$ 0,2305
(31,41%)
8,15M
SKKSKK Holdings Limited
US$ 1,62
(27,56%)
1,02M
NBTBNBT Bancorp Inc
US$ 63,24
(26,28%)
7
APLTApplied Therapeutics Inc
US$ 2,53
(-70,48%)
744k
RCKYRocky Brands Inc
US$ 17,04
(-22,09%)
12
PKOHPark Ohio Holdings Corporation
US$ 25,00
(-21,97%)
200
IDAIT Stamp Inc
US$ 0,6566
(-21,83%)
579,36k
PFCPremier Financial Corporation
US$ 22,01
(-21,05%)
101
PGHLPrimega Group Holdings Ltd
US$ 2,98
(80,61%)
9,27M
LGHLLion Group Holding Ltd
US$ 0,2305
(31,41%)
8,15M
BMRABiomerica Inc
US$ 0,4739
(47,13%)
3,68M
RGTIRigetti Computing Inc
US$ 2,63
(9,58%)
3,24M
SKKSKK Holdings Limited
US$ 1,63
(28,35%)
1,02M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen